Fiasp – going off-label. Being intentionally non-compliant!
Warning: What is discussed in this post is not recommended by the manufacturer and not aligned with the European Medicines Agency sign off for Fiasp. […]
Warning: What is discussed in this post is not recommended by the manufacturer and not aligned with the European Medicines Agency sign off for Fiasp. […]
One of the things that I’ve previously noted is that I’ve seen a fair amount of variability in using Fiasp, both in insulin sensitivity and […]
Today, for the first time in the UK, we ran a DIY Artificial Pancreas “Build Party”. What’s one of those? An occasion where a bunch […]
One of the biggest difficulties people with Diabetes have with MDI is timing insulin delivery. This isn’t helped by advice received from HCPs which tends […]
I’ve written about the various curveballs that Fiasp has thrown at me on multiple occasions, and for the past few weeks I’ve continued to observe […]
Back in 2013, in the US, Medtronic launched the 530G pump, and everyone and his dog called it an artificial pancreas. As Scott Hanselmann stated […]
Earlier today, the first NHS England CCG response to the Libre appeared on Twitter, from the East of England Priorities Advisory Committee. Looking to the […]
If there’s one thing I’ve learned from my experiences with Fiasp over the past month or so, it’s how important access to my data […]
So then. 10 days after switching back to Novorapid because I was having a devil of a time with the Fiasp, I received a new […]
Two days ago, Abbott announced they had received FDA approval for the Freestyle Libre, some 3 years after European approval. That feels like a long […]
Copyright © 2024 | WordPress Theme by MH Themes